7 results on '"van Marum, Rob J."'
Search Results
2. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards.
- Author
-
Joling, Karlijn J., Koppel, Maud ten, van Hout, Hein P.J., Onwuteaka‐Philipsen, Bregje D., Francke, Anneke L., Verheij, Robert A., Twisk, Jos W.R., and van Marum, Rob J.
- Subjects
PSYCHIATRIC drugs ,DEMENTIA ,DIAGNOSIS ,DRUG prescribing ,DRUGS ,SENILE dementia - Abstract
Background: Psychotropic drugs are frequently prescribed to people with dementia in nursing homes although severe adverse events and side effects are common. Less is known about the prevalence and types of psychotropic drug prescription in primary care for people with dementia. Objective: This study examined the prevalence of psychotropic drug prescriptions in primary care among persons with dementia from the year of diagnosis onwards. Methods: A longitudinal observational study using electronic health record (EHR) data was conducted. People with dementia were selected from EHR data of 451 general practices in the Netherlands. Age and gender‐adjusted psychotropic drug prescription rates were calculated per 1000 person‐years from the year the dementia diagnosis was first recorded in general practice up to 8 years after diagnosis. Results: Data of 15,687 patients were analyzed. The prescription rate of psychotropic drugs (not including antidementia drugs) was 420 per 1000 person‐years (95% CI 409; 431) in the first year after the recorded dementia diagnosis, which increased to 801 per 1000 person‐years (95% CI 649; 989) in the eighth year. The most frequently prescribed drugs were antidepressants, antipsychotics, and antidementia drugs, followed by anxiolytics, hypnotics, and antiepileptics. Conclusions: After a dementia diagnosis is recorded in general practice, the prevalence of psychotropic drug prescriptions is substantial and increases steadily during the disease trajectory of persons with dementia. Although the (in)appropriateness of prescribing was not assessed, these insights may stimulate primary care clinicians to (re)consider their prescription policy of psychotropics for people with dementia more carefully. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Patients' experiences with multidose drug dispensing: a cross sectional study.
- Author
-
Mertens, Bram J., Kwint, Henk-Frans, van Marum, Rob J., and Bouvy, Marcel L.
- Subjects
MEDICATION therapy management ,PHARMACY ,DRUG delivery systems ,DRUGS ,DRUG packaging ,PATIENT satisfaction ,SELF medication ,PATIENT participation ,CROSS-sectional method ,POLYPHARMACY - Abstract
Background Automated multidose drug dispensing is used to support patients with their medication management. Though multidose drug dispensing systems are frequently used, little is known about patients' experiences with multidose drug dispensing systems. Objective To explore patients' experiences with the initiation and use of multidose drug dispensing systems. Setting A survey was carried out with patients using multidose drug dispensing systems through three community pharmacies. Method A semi-structured interview protocol was designed based on existing literature and a pilot study. Main outcome measures The main outcome measures were (1) patients' experiences with initiating multidose drug dispensing systems and (2) patients' experienced advantages and disadvantages of multidose drug dispensing systems. Results The start of multidose drug dispensing was discussed with 76% of the patients (n = 62). Ninety percent of patients expressed the opinion that the multidose drug dispensing system supported them with their medication management. Sixty patients reported 110 advantages, which can be organized into the following categories: improved medication adherence and medication safety (59%); patient's convenience (40%); and other (1%). Sixty-nine percent of patients reported no disadvantages, 24% had problems opening the bags or outer packaging and 13% had problems with the legibility of the printed text on the bag. Conclusion In concordance with the Dutch guideline, patients are generally involved in the decision to initiate an multidose drug dispensing system. Patients are very satisfied using the system and report multiple advantages. Multidose drug dispensing systems may be further improved by simplifying the manual opening of the bags and improving the legibility of the text on the bags. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Are multidose drug dispensing systems initiated for the appropriate patients?
- Author
-
Mertens, Bram J., Kwint, H. F., van Marum, Rob J., and Bouvy, Marcel L.
- Subjects
ELDER care ,COGNITION ,COMMUNITY health workers ,DRUG delivery systems ,DRUGS ,DOSE-effect relationship in pharmacology ,FRAIL elderly ,HEALTH services administration ,INTERVIEWING ,NEUROPSYCHOLOGICAL tests ,RESEARCH methodology ,PATIENT compliance ,PHARMACISTS ,REGULATORY approval ,HOME environment ,HEALTH literacy ,MEDICATION therapy management ,PATIENTS' attitudes ,FUNCTIONAL assessment - Abstract
Purpose: It is unknown if multidose drug dispensing (MDD) systems are initiated for the appropriate patients. Therefore, the objective of this study was to compare the medication management problems of patients who were about to start with a MDD system (MDD patients) and patients who continued manually dispensed medication (non-MDD users) in order to identify if the appropriate patients receive a MDD system.Methods: Patient interviews (semi-structured) were conducted by 44 community pharmacists at the patient’s home. Patients over 65 years of age, home dwelling and using at least five chronic drugs, were eligible for the study. An assessment tool was developed including 22 potential medication management problems, covering four domains: functional (7), organizational (7), medication adherence (6), and medication knowledge (2). Median scores were calculated with the interquartile range. Additionally, cognitive function was assessed with the Mini-Cog and frailty using the Groningen Frailty Indicator.Results: One hundred eighty-eight MDD users and 230 non-MDD users were interviewed. MDD users were older, more often female, and using more drugs. Forty-two percent of the MDD users were possibly cognitively impaired and 63% were assessed as frail compared to 20 and 27% respectively of the non-MDD users. MDD users had more potential organizational problems (3 vs. 1; p < 0.01), functional problems (2 vs. 1; p < 0.01), medication adherence problems (1 vs. 0; p < 0.01), and medication knowledge problems (1 vs. 0; p < 0.01) compared to non-MDD users. Seventy percent of the MDD users scored six or more potential medication management problems while this was 22% among non-MDD users.Conclusions: The majority of MDD systems were initiated for patients who experienced multiple potential medication management problems suggesting a decreased medication management capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. An Electronic System to Document Reasons for Medication Discontinuation and to Flag Unwanted Represcriptions in Geriatric Patients.
- Author
-
van der Linden, Carolien M. J., Jansen, Paul A. F., van Marum, Rob J., Grouls, René J. E., Egberts, Toine C. G., and Korsten, Erik H. M.
- Subjects
ELECTRONICS ,DECISION support systems ,INFORMATION storage & retrieval systems ,MEDICAL databases ,DOCUMENTATION ,DRUGS ,DRUG side effects ,HOSPITAL care ,INTERVIEWING ,RESEARCH methodology ,MEDICAL history taking ,MEDICAL prescriptions - Abstract
Background: Earlier studies have shown poor documentation of the reasons for medication discontinuation during hospitalization. Communication of reasons for discontinuation, e.g. adverse drug reactions (ADRs), to general practitioners and pharmacists was also found to be insufficient, leading to a rate of represcription after an ADR of 27 % during the first 6 months after discharge. Objective: The aim of this study was to develop and implement a user-friendly electronic clinical decision support system to document reasons for medication discontinuation in hospitalized geriatric patients and to flag potentially undesirable represcriptions. Methods: The electronic clinical decision support module was developed using the Gaston framework. Pop-up windows force physicians to document reasons for medication discontinuation, and the system alerts physicians to the represcription of drugs withdrawn because of an ADR. We interviewed users regarding the acceptability of the system. Results On a 20-bed geriatric ward, the electronic system documented 2,228 medication discontinuations and the reasons for them over 11.4 months and alerted physicians to represcription of drugs associated with an ADR 20 times. The system was considered to be user-friendly. Conclusions This clinical decision support system fulfilled its aims of documenting the reasons for medication discontinuation and alerting physicians to potentially undesirable represcription of previously withdrawn drugs. It was found to be user-friendly. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
6. Relationship between polypharmacy and underprescribing.
- Author
-
Kuijpers, Mascha A. J., van Marum, Rob J., Egberts, Antoine C. G., and Jansen, Paul A. F.
- Subjects
- *
DRUGS , *PHARMACOPOEIAS , *DRUG prescribing , *MEDICAL prescriptions , *PATIENTS - Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Polypharmacy is common among the elderly. • Underprescribing is also frequent. • Optimizing polypharmacy includes avoiding underprescription. WHAT THIS STUDY ADDS • The probability of underprescription increases with the number of drugs used. • Forty-three % of patients who used five or more medicines are undertreated. • In undertreated patients a mean of 1.4 medicines were lacking. AIMS Underprescribing is increasingly recognized as an important problem. The aim of this study was to determine the relationship between polypharmacy and underprescribing. METHODS Treatment of current medical problems in geriatric patients was compared with general practitioner and national guidelines. Underprescription was defined as lack of an indicated drug, while no reason could be found for not prescribing it. Polypharmacy was defined as five or more drugs. RESULTS Polypharmacy was present in 61% of 150 patients. Underprescription was found in 47 (31%). Of patients with polypharmacy 42.9% were undertreated, in contrast to 13.5% of patients using four medicines or less (OR 4.8, 95% CI 2.0, 11.2). The estimated probability of underprescription increased significantly with the number of drugs. CONCLUSIONS We found a clear relationship between polypharmacy and underprescribing. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
7. To STOPP or to START? Potentially inappropriate prescribing in older patients with falls and syncope.
- Author
-
de Ruiter, Susanne C., Biesheuvel, Sophie S., van Haelst, Ingrid M.M., van Marum, Rob J., and Jansen, René W.M.M.
- Subjects
- *
OLDER patients , *SYNCOPE , *ORTHOSTATIC hypotension , *MEDICATION reconciliation , *DRUGS - Abstract
Objectives: To investigate the prevalence of potentially inappropriate prescribing (PIP) according to the revised STOPP/START criteria in older patients with falls and syncope.Study Design: We included consecutive patients with falls and syncope aged ≥65 years at the day clinic of the Northwest Clinics, the Netherlands, from 2011 to 2016. All medication use before and after the visit was retrospectively investigated using the revised STOPP/START criteria.Main Outcome Measures: The prevalence/occurrence of PIP before the visit, persistent PIP after the visit, and unaddressed persistent PIP not explained in the patient's chart.Results: PIP was present in 98 % of 374 patients (mean age 80 (SD ± 7) years; 69 % females). 1564 PIP occurrences were identified. 1015 occurrences persisted (in 91 % of patients). 690 occurrences (in 80 % of patients) were not explained in the patient's chart. The most frequent unaddressed persistent forms of PIP were prescriptions of vasodilator drugs for patients with orthostatic hypotension (16 %), and benzodiazepines for >4 weeks (10 %) or in fall patients (8 %), and omission of vitamin D (28 %), antihypertensive drugs (24 %), and antidepressants (17 %). 54 % of all medication changes were initiated for reasons beyond the scope of the STOPP/START criteria.Conclusions: Almost every patient in our study population suffered from PIP. In 80 %, PIP continued after the clinical visit, without an explanation in the patient's chart. The most frequent PIP concerned medication that increased the risk of falls or syncope, specifically vasodilator drugs and benzodiazepines. Physicians should be aware of PIP in older patients with falls and syncope. Further studies should investigate whether a structured medication review may improve clinical outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.